HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mee Joo Kang Selected Research

erucylphosphocholine

11/2023Conditional Relative Survival of Exocrine Pancreatic Cancer: A Population-Based Study.
11/2023Exocrine pancreatic cancer as a second primary malignancy: A population-based study.
1/2022First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mee Joo Kang Research Topics

Disease

25Neoplasms (Cancer)
11/2023 - 05/2010
7Pancreatic Neoplasms (Pancreatic Cancer)
11/2023 - 01/2016
6Pancreatic Fistula (Pancreatic Fistulas)
01/2022 - 05/2010
5Head and Neck Neoplasms (Head and Neck Cancer)
08/2022 - 04/2014
3Adenocarcinoma
01/2022 - 06/2016
3Klatskin Tumor
08/2014 - 02/2013
2Lymphatic Metastasis
11/2016 - 02/2014
2Diabetes Mellitus
03/2016 - 02/2016
2Neoplasms, Cystic, Mucinous, and Serous
09/2015 - 08/2014
1Hemorrhage
08/2022
1Weight Loss (Weight Reduction)
07/2022
1Malnutrition (Nutritional Deficiencies)
07/2022
1Body Weight (Weight, Body)
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Stomach Neoplasms (Stomach Cancer)
10/2020
1Portal Hypertension
10/2020
1Colorectal Neoplasms (Colorectal Cancer)
10/2020
1Polyps
09/2017
1Adenoma (Adenomas)
09/2017
1Insulin Resistance
03/2016
1Glucose Intolerance
02/2016
1Inflammation (Inflammations)
01/2016
1Surgical Wound Infection
01/2016
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2016
1Margins of Excision
06/2014
1Acute Cholecystitis
04/2014
1Disease Progression
04/2014
1Chromosome Aberrations (Chromosome Abnormalities)
03/2014
1Bile Duct Neoplasms (Bile Duct Cancer)
02/2013
1Wounds and Injuries (Trauma)
10/2012
1Peritonitis
10/2012
1Adenomyoma
05/2012
1Hamartoma
05/2012
1Carcinoma (Carcinomatosis)
01/2011
1Paraganglioma (Paragangliomas)
05/2010

Drug/Important Bio-Agent (IBA)

3erucylphosphocholineIBA
11/2023 - 01/2022
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2016
2Carcinoembryonic AntigenIBA
09/2015 - 12/2012
2BismuthIBA
04/2015 - 08/2014
1Serum AlbuminIBA
07/2022
1Ringer's LactateIBA
01/2022
1N-acetyltalosaminuronic acid (NAT)IBA
11/2021
1(N-piperidinomethyl)-2-chromanIBA
11/2020
1CholesterolIBA
09/2017
1Polyglycolic Acid (Polyglycolide)IBA
01/2017
1Prostaglandins AIBA
01/2017
1MicroRNAs (MicroRNA)IBA
06/2016
1Biomarkers (Surrogate Marker)IBA
06/2016
1Tumor Biomarkers (Tumor Markers)IBA
01/2016
1CarbohydratesIBA
09/2015
1AntigensIBA
09/2015
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
09/2015
1Genetic Markers (Genetic Marker)IBA
03/2014
1Oncostatin MIBA
03/2014
1MucinsIBA
05/2013
1Coloring Agents (Dyes)IBA
05/2012

Therapy/Procedure

9Pancreaticoduodenectomy
10/2022 - 05/2010
6Pancreatectomy
01/2017 - 08/2014
4Lymph Node Excision (Lymph Node Dissection)
01/2017 - 04/2014
3Drug Therapy (Chemotherapy)
10/2020 - 12/2012
3Cholecystectomy
04/2016 - 01/2011
3Hepatectomy
01/2016 - 02/2012
2Length of Stay
01/2022 - 01/2016
2Adjuvant Chemotherapy
04/2016 - 12/2012
2Catheters
04/2014 - 02/2013
1Nutritional Support (Artificial Feeding)
07/2022
1Neoadjuvant Therapy
11/2021
1Therapeutics
10/2020
1Bariatric Surgery
03/2016
1Adjuvant Chemoradiotherapy
06/2014
1Cholecystostomy
04/2014
1Radiotherapy
02/2014
1Conservative Treatment
10/2012